• phasq stock collapses 99% as phasebio bankruptcy restructuring continues Meyka Wed, 20 May 2026 06:05:04 GMT
• phasq stock plunges 99% in 2026: phasebio pharmaceuticals bankruptcy aftermath Meyka Sat, 11 Apr 2026 07:00:00 GMT
• phasq stock plunges 99% in 2026: phasebio pharmaceuticals bankruptcy aftermath Meyka Fri, 10 Apr 2026 23:16:29 GMT
• skye bioscience reduces employee stock option exercise prices and appoints new cfo Investing.com Fri, 03 Apr 2026 07:00:00 GMT
• phasq falls 99.00% to $0.000001 on 03 apr 2026: immediate liquidity risk Meyka Fri, 03 Apr 2026 07:00:00 GMT
• phasq down 99.00% to $0.000001 (pnk): phasq stock outlook and next signals Meyka Mon, 23 Mar 2026 07:00:00 GMT
• phasq stock slumps 99% on pnk 19 mar 2026: clear risk for investors Meyka Thu, 19 Mar 2026 07:00:00 GMT
• Medical Marijuana, Recreational Cannabis, and Cardiovascular Health professional.heart.org Tue, 17 Mar 2026 10:57:11 GMT
• phasq stock down 99% in market hours 12 mar 2026: key risks for traders Meyka Thu, 12 Mar 2026 07:00:00 GMT
• phasq phasebio (pnk) down 99% on 09 mar 2026: what we watch next Meyka Mon, 09 Mar 2026 07:00:00 GMT
• phasq phasebio pharmaceuticals, inc. (pnk) down 99% 05 mar 2026: key risks ahead Meyka Thu, 05 Mar 2026 08:00:00 GMT
• phasq (phasebio pharmaceuticals, pnk) down 99% on 26 feb 2026: key risks ahead Meyka Thu, 26 Feb 2026 08:00:00 GMT
• phasq stock plunges 99.00% to $0.000001 on 23 feb 2026: key analyst takeaway Meyka Mon, 23 Feb 2026 16:35:01 GMT
• phasq falls 99% to $0.000001 pnk us: liquidity questions weigh on outlook Meyka Fri, 20 Feb 2026 08:00:00 GMT
• financialcontent - phio pharmaceuticals aligns leadership team to support next stage development of ph-762 and advancement of ph-8... FinancialContent Thu, 19 Feb 2026 12:00:00 GMT
• phio reshapes leadership as ph-762 cancer drug nears key tests Stock Titan Thu, 19 Feb 2026 08:00:00 GMT
• phio pharmaceuticals aligns leadership team to support next stage development of ph-762 and advancement of ph-894 FinancialContent Thu, 19 Feb 2026 08:00:00 GMT
• phasq stock plunges 99.00% to $0.000001 on pnk 17 feb 2026: what traders should watch Meyka Tue, 17 Feb 2026 08:00:00 GMT
• phasq phasebio pharmaceuticals (pnk) down 99% on 12 feb 2026: key risks ahead Meyka Thu, 12 Feb 2026 16:34:08 GMT
• phasq phasebio (pnk) falls to $0.000001 on 30 jan 2026: top loser, delisting Meyka Fri, 30 Jan 2026 08:00:00 GMT
• phasq phasebio (pnk) at $0.000001 on 28 jan 2026: top losers insight Meyka Wed, 28 Jan 2026 08:00:00 GMT
• Corxel raises USD 287m in Series D1 as oral GLP-1 RA set for Phase III AllSci Thu, 22 Jan 2026 08:00:00 GMT
• phasq stock falls to usd 0.000001 on pnk 22 jan 2026: top loser insight Meyka Thu, 22 Jan 2026 08:00:00 GMT
• phasq phasebio pharmaceuticals (pnk) plunges 99.00% on 20 jan 2026: liquidity risk needs monitoring Meyka Tue, 20 Jan 2026 08:00:00 GMT
• phasq phasebio (pnk) drops 99% on jan 15 2026: top loser, cash runway risk Meyka Thu, 15 Jan 2026 08:00:00 GMT
• phasq stock down 99% to $0.000001 on pnk 09 jan 2026: what traders should watch Meyka Fri, 09 Jan 2026 08:00:00 GMT
• phasq down 99.0% to $0.000001 on 03 jan 2026 market hours: key concern Meyka Sat, 03 Jan 2026 01:56:02 GMT
• pulmonary arterial hypertension pipeline outlook report 2025: openPR.com Sun, 26 Oct 2025 07:00:00 GMT
• short bowel syndrome pipeline drugs insights report 2025: openPR.com Wed, 15 Oct 2025 12:36:06 GMT
• monoclonal gammopathy of undetermined significance (mgus) management market Future Market Insights Thu, 04 Sep 2025 07:00:00 GMT
• short bowel syndrome pipeline outlook 2025: clinical trial openPR.com Fri, 29 Aug 2025 16:28:03 GMT
• why i've started a small short in phasebio pharmaceuticals (otcmkts:phasq) Seeking Alpha Fri, 29 Aug 2025 01:56:10 GMT
• achondroplasia treatment market on track for massive expansion by 2035, forecasts reveal. newstrail.com Tue, 19 Aug 2025 19:34:10 GMT
• diagonal therapeutics appoints john lee, m.d., ph.d., as chief medical officer GlobeNewswire Tue, 08 Jul 2025 07:00:00 GMT
• phio pharmaceuticals advances 30-drug cancer portfolio as phase 1b trial shows promise Stock Titan Fri, 06 Jun 2025 07:00:00 GMT
• phio pharmaceuticals announces strategic initiative to create awareness of the comprehensive intasyl sirna portfolio Newsfile Fri, 06 Jun 2025 07:00:00 GMT
• uncontrolled bleeding treatment market size in 7mm is expected to grow at a decent cagr by 2032, estimates delveinsight The Globe and Mail Mon, 12 May 2025 23:02:00 GMT
• global restrictive cardiomyopathy treatment market to surpass usd 195.5 million by 2035 | fmi newstrail.com Tue, 29 Apr 2025 07:00:00 GMT
• monoclonal antibody bentracimab shown to reverse antiplatelet effect of brilinta | acc 2025 Managed Healthcare Executive Tue, 01 Apr 2025 07:00:00 GMT
• soul: oral semaglutide cuts mace by 14% in people with type 2 diabetes MD Magazine Sat, 29 Mar 2025 18:37:08 GMT
• oral semaglutide cuts cardiovascular risk by 14% in soul trial AJMC.com Managed Markets Network Sat, 29 Mar 2025 18:32:24 GMT
• REVERSE-IT: Bentracimab Effective in Reversing Ticagrelor Antiplatelet Effects HCP Live Sat, 29 Mar 2025 07:00:00 GMT
• ticagrelor antidote bentracimab safely reverses antiplatelet effects in phase 3 reverse-it trial AJMC Sat, 29 Mar 2025 07:00:00 GMT
• ticagrelor antidote safely, effectively restores platelet function and treats bleeding American College of Cardiology Sat, 29 Mar 2025 07:00:00 GMT
• bentracimab reverses ticagrelor's antiplatelet effects during surgery and bleeding events News-Medical Sat, 29 Mar 2025 07:00:00 GMT
• stride: semaglutide shows it has legs in peripheral artery disease MedPage Today Sat, 29 Mar 2025 07:00:00 GMT
• pulmonary arterial hypertension clinical trials and studies: ema, pdma, fda approvals, mechanism of action, roa, nda, ind, and com... The Globe and Mail Wed, 12 Mar 2025 18:37:18 GMT
• Duke University Professor Ashutosh Chilkoti honored with 2025 Technology Innovation and Development Award by the Society for Bioma... The Indian EYE Wed, 19 Feb 2025 08:00:00 GMT
• global transmucosal drugs market to reach ~usd 28 billion by 2032 | delveinsight PR Newswire Tue, 18 Feb 2025 08:00:00 GMT
• pulmonary arterial hypertension clinical trials and studies: ema, pdma, fda approvals, mechanism of action, EIN News Thu, 13 Feb 2025 12:26:00 GMT
• medpharm appoints bill humphries as chief executive officer to lead next phase of strategic growth PR Newswire Tue, 04 Feb 2025 08:00:00 GMT
• advancements in ocular hypertension clinical trial pipeline GlobeNewswire Tue, 21 Jan 2025 06:46:25 GMT
• heart failure with reduced ejection fraction market to expand significantly by 2032, states delveinsight EIN News Mon, 20 Jan 2025 21:10:00 GMT
• Advancements in Ocular Hypertension Clinical Trial Pipeline GlobeNewswire Mon, 20 Jan 2025 08:00:00 GMT
• why i've started a small short in phasebio pharmaceuticals (otcmkts:phasq) Seeking Alpha Tue, 07 Jan 2025 20:43:16 GMT
• The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender MedCity News Thu, 26 Dec 2024 08:00:00 GMT
• acute heart failure (ahf) therapeutics market report overview Business Research Insights Mon, 23 Dec 2024 08:00:00 GMT
• johnson & johnson innovation – jjdc - investor profile, portfolio & team Tracxn Mon, 02 Dec 2024 08:00:00 GMT
• phasq (phasebio pharmaceuticals) other current assets : $3.76 mil (as of jun. 2022) GuruFocus.com Thu, 28 Nov 2024 04:31:28 GMT
• as top investor makes its play to grab lead drug, phasebio counters with chapter 11, stalking-horse bid Endpoints News Sat, 26 Oct 2024 07:00:00 GMT
• philadelphia-area life sciences industry nears 900 layoffs since 2022 BioBuzz Fri, 18 Oct 2024 07:00:00 GMT
• philadelphia-area life sciences industry nears 900 layoffs since 2022 The Business Journals Fri, 11 Oct 2024 07:00:00 GMT
• navigating uncertainty: the financial and ethical challenges in biotech restructuring ABF Journal Wed, 09 Oct 2024 07:00:00 GMT
• barriers and facilitators to implementation of intravenous cardiovascular treatments in ambulatory settings Wiley Online Library Wed, 25 Sep 2024 07:00:00 GMT
• acute heart failure (ahf) therapeutics industry size, share, price, trends, forecast (2024-2034) Third Eye News Mon, 23 Sep 2024 08:23:02 GMT
• head-to-head analysis: evolus (nasdaq:eols) & phasebio pharmaceuticals (nasdaq:phas) Defense World Mon, 26 Aug 2024 05:43:27 GMT
• phasq (phasebio pharmaceuticals) ev-to-revenue : -1.19 (as of aug. 16, 2024) GuruFocus.com Sat, 17 Aug 2024 02:28:20 GMT
• phasebio reports monthly operating results amid bankruptcy by investing.com Investing.com Australia Fri, 16 Aug 2024 14:22:21 GMT
• phasebio reports monthly operating results amid bankruptcy Investing.com Thu, 15 Aug 2024 21:56:15 GMT
• achondroplasia market is expected to show a significant growth during the forecast period | pfizer, sanofi, prolynx, phasebio, asc... Barchart.com Thu, 15 Aug 2024 07:00:00 GMT
• acute respiratory distress syndrome market size in 7mm was ~usd 941 million in 2023, asserts delveinsight | medicinova, edesa biot... Barchart.com Tue, 30 Jul 2024 07:00:00 GMT
• short bowel syndrome market positive outlook: phase bio , orphan technologies , zealand pharma Newstrail Sat, 27 Jul 2024 07:00:00 GMT
• lipoprotein(a) as a cardiovascular risk factor among patients with and without diabetes mellitus: the mass general brigham lp(a) r... Cardiovascular Diabetology Thu, 18 Jul 2024 07:00:00 GMT
• phasebio announces bankruptcy plan confirmation by investing.com Investing.com Australia Sat, 13 Jul 2024 07:00:00 GMT
• jefferies upgrades cooper companies stock to 'buy', highlights growth prospects by investing.com Investing.com Fri, 12 Jul 2024 23:00:19 GMT
• phasebio explodes 82% after-hours on fda nod for covid-19 clinical trial TipRanks Thu, 04 Jul 2024 10:39:12 GMT
• pentixapham acquires antibody discovery business from glycotope Pharmaceutical Technology Thu, 04 Jul 2024 07:00:00 GMT
• sanotize appoints john sharp as chief financial officer World Business Outlook Sun, 23 Jun 2024 10:03:13 GMT
• achondroplasia pipeline analysis 2024: fda approvals and emerging therapies | ascendis pharma, bridgebio ... Barchart Thu, 20 Jun 2024 13:23:00 GMT
• phasebio pharmaceuticals, inc. (phas) shares march higher, can it continue? Yahoo Movies UK Tue, 18 Jun 2024 07:41:47 GMT
• phasebio announces bankruptcy plan confirmation by investing.com Investing.com Fri, 14 Jun 2024 07:00:00 GMT
• strong week for phasebio pharmaceuticals (nasdaq:phas) shareholders doesn't alleviate pain of three-year loss Yahoo New Zealand News Wed, 29 May 2024 23:54:40 GMT
• acute liver failure treatment market size, outlook, swot & forecast 2033 Verified Market Reports Thu, 23 May 2024 11:28:14 GMT
• financial comparison: q32 bio (nasdaq:qttb) vs. phasebio pharmaceuticals (nasdaq:phas) Defense World Wed, 15 May 2024 07:00:00 GMT
• do options traders know something about phasebio pharmaceuticals (phas) stock we don't? Yahoo New Zealand News Fri, 10 May 2024 05:23:06 GMT
• ers international congress 2016 - cardio-vascular, one to watch companies The Pharma Letter Wed, 08 May 2024 21:48:34 GMT
• do options traders know something about phasebio pharmaceuticals (phas) stock we don't? Yahoo New Zealand News Sun, 05 May 2024 12:00:01 GMT
• do options traders know something about phasebio pharmaceuticals (phas) stock we don't? Yahoo New Zealand News Sat, 04 May 2024 22:45:59 GMT
• did you manage to avoid phasebio pharmaceuticals's (nasdaq:phas) 21% share price drop? Yahoo Movies UK Sat, 04 May 2024 13:05:12 GMT
• phasebio pharma (phas) reports q2 loss, lags revenue estimates Yahoo Canada Shine On Fri, 03 May 2024 20:53:00 GMT
• did you manage to avoid phasebio pharmaceuticals's (nasdaq:phas) 21% share price drop? Yahoo Movies UK Fri, 03 May 2024 14:11:22 GMT
• effect of reconstituted human apolipoprotein a-i on recurrent ischemic events in survivors of acute mi ScienceDirect.com Fri, 03 May 2024 12:48:40 GMT
• did you manage to avoid phasebio pharmaceuticals's (nasdaq:phas) 21% share price drop? Yahoo Movies UK Mon, 29 Apr 2024 05:12:43 GMT
• pulmonary arterial hypertension pipeline outlook report 2024 (updated) openPR.com Tue, 16 Apr 2024 07:00:00 GMT
• chutes & ladders—top bio lobbyist quickly exits after biosecure reversal Fierce Biotech Fri, 12 Apr 2024 07:00:00 GMT
• nuevocor strengthens leadership team with appointment of john lee as chief medical officer PR Newswire Thu, 11 Apr 2024 07:00:00 GMT
• treatment-resistant hypertension market is anticipated to GlobeNewswire Tue, 09 Apr 2024 07:00:00 GMT
• effect of reconstituted human apolipoprotein a-i on recurrent ischemic events in survivors of acute mi JACC Journals Sat, 06 Apr 2024 07:00:00 GMT
• reviewing immunoprecise antibodies (nasdaq:ipa) & phasebio pharmaceuticals (nasdaq:phas) Defense World Mon, 01 Apr 2024 05:53:00 GMT
• short bowel syndrome market size in the 7mm was ~usd 2300 million in 2023, estimated delveinsight WICZ Sun, 31 Mar 2024 07:00:00 GMT
• impahct: a randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertension Wiley Online Library Mon, 25 Mar 2024 07:00:00 GMT
• acute heart failure (ahf) therapeutics global strategic GlobeNewswire Fri, 01 Mar 2024 08:00:00 GMT
• phasebio pharmaceuticals (nasdaq:phas) versus united therapeutics (nasdaq:uthr) critical analysis AmericanBankingNEWS Wed, 28 Feb 2024 11:20:44 GMT
• united therapeutics (nasdaq:uthr) and phasebio pharmaceuticals (nasdaq:phas) critical analysis Defense World Wed, 28 Feb 2024 11:19:22 GMT
• pulmonary arterial hypertension market to witness growth by 2032, estimates delveinsight | merck, united ... Coin Plus（コインプラス） Wed, 28 Feb 2024 07:46:34 GMT
• goldilocks and the 'not great, but good enough': drug development shops offer 'sweet spot' deal alternative Fierce Biotech Tue, 27 Feb 2024 08:00:00 GMT
• alex sapir net worth - insider trades and bio as of apr 22, 2026 Benzinga Mon, 12 Feb 2024 07:08:35 GMT
• achondroplasia treatment market projected to reach usd 3.2 GlobeNewswire Thu, 01 Feb 2024 08:00:00 GMT
• resistant hypertension therapeutics market see huge growth for new normal | bayer ag, novartis ag, sarfez ... Future of Media Thu, 11 Jan 2024 21:57:27 GMT
• Achondroplasia Treatment Drug Market to Register Positive Growth by 2032, Assesses DelveInsight | Key Companies in the Market - As... PR Newswire Tue, 09 Jan 2024 08:00:00 GMT
• acute heart failure (ahf) therapeutics market size, overview, potential & forecast 2033 Verified Market Reports Tue, 02 Jan 2024 03:00:04 GMT
• pulmonary arterial hypertension market forecast 2024-2030: advancements in cardiovascular care WhaTech Thu, 28 Dec 2023 08:00:00 GMT
• cardiomyopathy medication market (2023-2029):pfizer, phasebio pharmaceuticals, astrazeneca, roche, johnson ... Artrocker Wed, 13 Dec 2023 05:21:56 GMT
• pulmonary arterial hypertension pipeline and clinical trials ... Digital Journal Mon, 04 Dec 2023 19:49:11 GMT
• csl (otcmkts:cslly) and phasebio pharmaceuticals (nasdaq:phas) critical survey Defense World Mon, 04 Dec 2023 08:00:00 GMT
• an explainable machine learning-based phenomapping strategy for ... Nature.com Sat, 25 Nov 2023 08:00:00 GMT
• ocular hypertension market size and share to increase by GlobeNewswire Wed, 22 Nov 2023 08:00:00 GMT
• phasebio pharmaceuticals, inc. – with debtor still locking horns with sfj (this time over a contested $9.6mn ... Bankrupt Company News Fri, 10 Nov 2023 08:00:00 GMT
• phasebio pharmaceuticals, inc. – with debtor still locking horns with sfj (this time over a contested $9.6mn ... Bankrupt Company News Wed, 08 Nov 2023 23:48:38 GMT
• 4e brands northamerica llc – u.s. trustee, citing "foundational ... Bankrupt Company News Fri, 03 Nov 2023 07:00:00 GMT
• pulmonary arterial hypertension pipeline insights report 2023 (updated) openPR.com Thu, 02 Nov 2023 07:00:00 GMT
• efficacy of sotagliflozin in adults with type 2 diabetes in relation to baseline hemoglobin a1c ScienceDirect.com Mon, 30 Oct 2023 18:55:25 GMT
• revascularization after treatment of in-stent restenosis high after 10 ... Healio Fri, 27 Oct 2023 07:00:00 GMT
• sustained mitral regurgitation reduction for high-risk patients with ... Healio Thu, 26 Oct 2023 07:00:00 GMT
PhaseBio Pharmaceuticals, Inc(NASDAQ:PHAS) 
PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel for cardiopulmonary diseases. Its lead product candidate is bentracimab (PB2452), a reversal agent for the antiplatelet drug ticagrelor that is in Phase III clinical ...
Website: http://www.phasebio.com
Founded: 2002
Full Time Employees: 50 (May 2021)
Sector: Healthcare
Industry: Biotechnology